EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -0.6484
March 31, 2026 -0.6814
September 30, 2025 -0.9164
June 30, 2025 -0.958
March 31, 2025 -0.8948
September 30, 2024 -1.048
June 30, 2024 -0.8597
March 31, 2024 -0.7632
December 31, 2023 -0.8508
September 30, 2023 -0.745
June 30, 2023 -0.7877
March 31, 2023 -0.6199
December 31, 2022 -0.7097
September 30, 2022 -0.8522
June 30, 2022 -0.9934
March 31, 2022 -1.408
December 31, 2021 -1.271
September 30, 2021 -1.317
June 30, 2021 -1.285
March 31, 2021 -1.304
December 31, 2020 -1.433
Date Value
September 30, 2020 -1.638
June 30, 2020 -1.969
March 31, 2020 -2.208
December 31, 2019 -2.290
September 30, 2019 -2.163
June 30, 2019 -1.850
March 31, 2019 -1.308
December 31, 2018 -1.369
September 30, 2018 -2.868
June 30, 2018 -3.235
March 31, 2018 -3.844
December 31, 2017 -3.926
September 30, 2017 -1.976
June 30, 2017 -1.301
March 31, 2017 -0.7437
December 31, 2016 -0.3819
September 30, 2016 -0.3819
June 30, 2016 -0.3819
March 31, 2016 -0.2114
December 31, 2015 0.00

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
MediGene AG --
BioNTech SE -7.847
Immatics NV -1.849
Beam Therapeutics, Inc. -0.86
Kymera Therapeutics, Inc. -3.242